Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000539148 | SCV000644474 | benign | Tuberous sclerosis 2 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565068 | SCV000675673 | likely benign | Hereditary cancer-predisposing syndrome | 2020-02-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Johns Hopkins Genomics, |
RCV000539148 | SCV001433642 | likely benign | Tuberous sclerosis 2 | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001650884 | SCV001866943 | benign | not provided | 2020-12-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000539148 | SCV002039374 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043288 | SCV000067090 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |